Nestlé has announced a strategic overhaul of its R&D operations, focusing on enhancing its capabilities in biotechnology and establishing a pioneering centre for deep tech.

This move aims to streamline innovation processes and align with evolving consumer demands in the food and beverage sector.

In a bid to create an industry-leading R&D framework, Nestlé plans to implement a leaner organisational structure that emphasises agility and efficiency. The restructuring will allow for the redeployment of existing resources and the prioritiation of impactful projects, ultimately driving innovation across various product lines.

Laurent Freixe, CEO of Nestlé, highlighted the importance of these advancements: "These new capabilities in biotech and deep tech will fuel growth by meeting changing consumer needs and accelerating the digital transformation of Nestlé." The initiative is part of what the company refers to as the 'Nestlé Virtuous Circle,' which aims to unlock investments through operational efficiencies.

The enhanced focus on biotechnology is expected to yield significant advancements in nutritional solutions. Nestlé’s R&D will now have increased expertise in clinical research, which will bolster its offerings in maternal and early life nutrition, as well as medical nutrition. The company is also targeting emerging growth areas such as healthy longevity, women’s health and weight management.

Key innovations include the development of next-generation screening assays and precision fermentation techniques. These advancements are anticipated to lead to new bio-actives and biotics, including post- and synbiotics, that can enhance both human and pet nutrition.

Nestlé's commitment to deep tech is underscored by the establishment of a new centre dedicated to this field, marking a first in the food and nutrition industry. Set to open in 2026 at the Nestlé System Technology Center in Orbe, Switzerland, the centre will focus on developing advanced sensor systems, AI solutions and robotics. These technologies aim to improve operational efficiency and facilitate the creation of innovative products, such as smart coffee machines and self-regulating equipment.

Stefan Palzer, CTO of Nestlé, emphasised the transformative nature of these initiatives, stating: "We continue to transform our R&D organisation to embrace science and technology trends and to seize current and future growth opportunities".

He continued: "The industry-leading biotechnology capabilities will deliver new ingredients with clinically proven bio-efficacy for precision nutrition for people and pets along their entire lifespan. The upscaling of our unique capabilities in deep tech are key to maximise efficiency in innovation and operations. And all of this is powered by a leaner and more agile R&D organisation."